The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Clopidogrel is a antiplatelet agent and is effective at reducing intimal hyperplasia in
animal models of thrombosis.Several large clinical trials have demonstrated that clopidogrel
with aspirin can reduce ischemic events and mortality in patients with atherosclerotic
disease,therefore the combination of two antiplatelets might be useful to prevent patients
received coronary artery bypass graft surgery from Saphenous vein graft disease. the aim of
this study is to estimate the safety and efficacy of clopidogrel and aspirin therapy versus
aspirin alone in patients after CABG.